How big is the complicated urinary tract infections market | Size, Trends & 2025 Forecast

Q: What is the current size of the complicated urinary tract infections market? Complicated urinary tract infections market is driven by antibiotic resistance, hospital-based infections, and advancements in diagnostics and therapeutics.

The complicated urinary tract infections market was valued at USD 9.8 billion in 2024 and is projected to reach USD 18.7 billion by 2031.

Q: What is the growth rate of the complicated urinary tract infections market?

The market is anticipated to grow at a CAGR of 9.7% between 2025 and 2031.

Q: Which components contribute the most to the complicated urinary tract infections market?

Key contributors include novel antibiotics, point-of-care diagnostic tools, and hospital-based therapeutic programs.

Q: What is driving demand in the complicated urinary tract infections market?

Rising multidrug resistance, increased ICU admissions, and improved diagnostic solutions are fueling market demand.

Q: What challenges does the complicated urinary tract infections market face?

The market faces challenges like high drug development costs, regulatory hurdles, and limited availability of new antibiotics.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5854

Publication Date: Jul 2025

How big is the Complicated Urinary Tract Infections Market?

According to 6Wresearch internal database and industry insights, Global complicated urinary tract infections market was valued at approximatelyUSD 9.8 billion in 2024 and is projected to reachUSD 18.7 billion by 2031, growing at aCAGR of 9.7% during the forecast period.

View Main Report

Schedule Analyst Call

The market is expanding steadily, driven by rising antibiotic resistance, aging populations, and increasing hospital-acquired infections globally.

Key Growth Drivers of the Complicated Urinary Tract Infections Market

Increasing prevalence of catheter-associated and recurrent urinary tract infections
Growing antibiotic resistance prompting the need for novel therapeutics
Rising geriatric population and comorbidities like diabetes and kidney disorders
Accelerated approvals and support for antimicrobial R&D initiatives
Surge in hospitalization and ICU admissions leading to increased cUTI risk

Complicated Urinary Tract Infections Market Trends

The Complicated Urinary Tract Infections Market is witnessing strong research activity into narrow-spectrum and combination antibiotics designed to combat drug-resistant uropathogens. Government agencies and pharmaceutical companies are investing in next-generation treatments including beta-lactamase inhibitors, phage therapy, and bacteriophage cocktails. The use of point-of-care diagnostics is becoming more prominent to enable rapid pathogen identification and targeted therapy. Personalized medicine approaches are also gaining ground to improve treatment efficacy and reduce side effects.

Emerging Developments in the Complicated Urinary Tract Infections Market

Advancements in IV-to-oral antibiotic conversion therapies and single-dose infusion drugs are improving outpatient care efficiency. Several pipeline drugs with novel mechanisms are being developed for multi-drug resistant cUTIs. Increasing use of AI for predictive diagnosis and antibiotic stewardship is helping healthcare systems manage treatment better. Strategic partnerships between biotech firms and global health organizations are fast-tracking product development and deployment in high-burden regions.